Carson Wealth (CWM LLC)’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-961
| Closed | -$6K | – | 5383 |
|
|
2025
Q1 | $6K | Sell |
961
-8,406
| -90% | -$44.3K | ﹤0.01% | 4420 |
|
|
2024
Q4 | $35K | Buy |
9,367
+6,767
| +260% | +$31.2K | ﹤0.01% | 3068 |
|
|
2024
Q3 | $15K | Buy |
2,600
+1,531
| +143% | +$10.7K | ﹤0.01% | 3568 |
|
|
2024
Q2 | $9K | Buy |
1,069
+322
| +43% | +$3.43K | ﹤0.01% | 3639 |
|
|
2024
Q1 | $11K | Buy |
747
+43
| +6% | +$711 | ﹤0.01% | 3309 |
|
|
2023
Q4 | $15K | Sell |
704
-156
| -18% | -$2.78K | ﹤0.01% | 2962 |
|
|
2023
Q3 | $17K | Buy |
860
+268
| +45% | +$5.72K | ﹤0.01% | 2808 |
|
|
2023
Q2 | $15K | Buy |
592
+13
| +2% | +$375 | ﹤0.01% | 2848 |
|
|
2023
Q1 | $21K | Sell |
579
-103
| -15% | -$3.62K | ﹤0.01% | 2489 |
|
|
2022
Q4 | $27K | Sell |
682
-20
| -3% | -$832 | ﹤0.01% | 2167 |
|
|
2022
Q3 | $33K | Sell |
702
-79
| -10% | -$3.67K | ﹤0.01% | 1899 |
|
|
2022
Q2 | $34K | Buy |
781
+24
| +3% | +$1.32K | ﹤0.01% | 1825 |
|
|
2022
Q1 | $55K | Buy |
757
+173
| +30% | +$12.5K | ﹤0.01% | 1567 |
|
|
2021
Q4 | $47K | Buy |
+584
| New | +$58.5K | ﹤0.01% | 1600 |
|
Other funds holding NVRO
Carson Wealth (CWM LLC)'s NVRO Position: Q2 2025 in Review
Carson Wealth (CWM LLC) sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 961 shares — an estimated $6K sold.
Carson Wealth (CWM LLC) first reported a position in NVRO in Q4 2021 and held it in 14 quarters. The position peaked at $55K in Q1 2022. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Carson Wealth (CWM LLC) reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Carson Wealth (CWM LLC) sold 961 NEVRO CORP. shares in Q2 2025, an estimated $6K.
- Carson Wealth (CWM LLC) first reported a position in NEVRO CORP. in Q4 2021 and held it in 14 quarters.
- Carson Wealth (CWM LLC)'s NEVRO CORP. position peaked at $55K in Q1 2022.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2025, filed 25 Jul 2025.